nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0983	0.0983	CbGpPWpGaD
Metoprolol—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0492	0.0492	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0424	0.0424	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0414	0.0414	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0361	0.0361	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0353	0.0353	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0351	0.0351	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0343	0.0343	CbGpPWpGaD
Metoprolol—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0341	0.0341	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0327	0.0327	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.032	0.032	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0304	0.0304	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0297	0.0297	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0295	0.0295	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0288	0.0288	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0275	0.0275	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0269	0.0269	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0229	0.0229	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0224	0.0224	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0192	0.0192	CbGpPWpGaD
Metoprolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.019	0.019	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0188	0.0188	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0157	0.0157	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0152	0.0152	CbGpPWpGaD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.0134	0.0134	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00994	0.00994	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00748	0.00748	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00697	0.00697	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00682	0.00682	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00677	0.00677	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00662	0.00662	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0063	0.0063	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00617	0.00617	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00607	0.00607	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00597	0.00597	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00584	0.00584	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0058	0.0058	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00573	0.00573	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00567	0.00567	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0054	0.0054	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00528	0.00528	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00455	0.00455	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00445	0.00445	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00442	0.00442	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00442	0.00442	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00432	0.00432	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00432	0.00432	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00415	0.00415	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00411	0.00411	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00402	0.00402	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00378	0.00378	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0037	0.0037	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00308	0.00308	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00288	0.00288	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00282	0.00282	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00257	0.00257	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00251	0.00251	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0025	0.0025	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00244	0.00244	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00233	0.00233	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00228	0.00228	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00227	0.00227	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00227	0.00227	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00227	0.00227	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00222	0.00222	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00214	0.00214	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00211	0.00211	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00206	0.00206	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00168	0.00168	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00163	0.00163	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00159	0.00159	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00148	0.00148	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00145	0.00145	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00138	0.00138	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00135	0.00135	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00134	0.00134	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00125	0.00125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00122	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000873	0.000873	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000854	0.000854	CbGpPWpGaD
